Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Optibrium Strengthens Global AI Drug Discovery Software Operations With Three Key Appointments
Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, today […]
Liverpool Heart and Chest Hospital Selects Clinical Informatics Provider Epro as Digital Partner
Leading healthcare informatics provider Epro has been selected by the Liverpool Heart and Chest Hospital (LHCH) to […]
Olympus Launches THUNDERBEAT Energy Device for Open Surgery
Olympus Corporation (Olympus), a global medtech company committed to making people’s lives healthier, safer, and […]
First-Ever Spinal Surgical Hand-held Robot by Point Robotics MedTech to Make Its Worldwide Debut in the United States
Point Robotics MedTech Inc. (Point Robotics), a rising star in the field of orthopedic surgery, […]
Novavax Makes One Million Doses of Nuvaxovid™ Available for Use in the United Kingdom
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for […]
Dystrogen Therapeutics Investigational Chimeric Cell Therapy DT-DEC01 for Duchenne Muscular Dystrophy Demonstrates Clinically Significant Functional and Biomarker Improvements
Dystrogen Therapeutics, Corp. the leader in chimeric cell therapies, today announced positive 6-month results from […]
Surge Raises $2.6M, Secures Exclusive Licensing Agreement with Stanford to Make Surgeries Safer
Biotech and medical AI innovator Surge announced a $2.6 million round co-led by HCVC, a global early-stage fund dedicated […]
Malaysian Genomics Grows Presence in Thailand
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is […]
Vivalink Releases Biometrics Data Platform 2.0, Increasing Remote Patient Monitoring Patient Adherence
Vivalink, a leading provider of digital healthcare solutions, has released an updated version of its […]
Novo Nordisk Foundation Launches Major Investment to Develop the First Quantum Computer Dedicated to Life Sciences Research and the Green Transition
The Novo Nordisk Foundation has awarded a grant of US$ 200 million (DKK 1.5 billion) to establish […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more